IBC represents a particular clinical type of breast cancer characterized by an high aggressiveness with a poor prognosis. A combined therapeutical approach (chemotherapy, surgery, radiotherapy and hormonotherapy is necessary to obtain a better control of disease and to improve the prognosis. In the last years a new therapeutical strategy (neoadjuvant chemotherapy followed by surgery and then maintenance chemotherapy + radiotherapy) has been activated with our departments. Satisfactory results, either for disease-free survival or for over-all survival, have been found.
Inflammatory breast cancer (IBC) management / A., Santoro; L., Maiorino; M., Santoro; Quarto, Gennaro; Forestieri, Pietro. - STAMPA. - (1996), pp. 603-606. (Intervento presentato al convegno 10th Mediterranean Congress of Chemotherapy tenutosi a ANTALYA, TURKEY nel 1996).
Inflammatory breast cancer (IBC) management
QUARTO, GENNARO;FORESTIERI, PIETRO
1996
Abstract
IBC represents a particular clinical type of breast cancer characterized by an high aggressiveness with a poor prognosis. A combined therapeutical approach (chemotherapy, surgery, radiotherapy and hormonotherapy is necessary to obtain a better control of disease and to improve the prognosis. In the last years a new therapeutical strategy (neoadjuvant chemotherapy followed by surgery and then maintenance chemotherapy + radiotherapy) has been activated with our departments. Satisfactory results, either for disease-free survival or for over-all survival, have been found.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
